[1] |
陈桂青. 入院24 h平均血糖对重症脓毒血症患者预后的影响[J]. 中外医疗,2012,31(6):57-58.
|
[2] |
ZENI F,FREEMAN B,NATANSON C.Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment[J] . Crit Care Med,1997,25(7):1095-1100.
|
[3] |
BONE RC,BALK RA,CERRA FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest,1992,101(6):1644-1655.
|
[4] |
VAN LE L,FAKHRY S,WALTON LA,et al.Use of the APACHE Ⅱ scoring system to determine mortality of gynecologic oncology patients in the intensive care unit[J]. Obstet Gynecol,1995,85(1):53-56.
|
[5] |
王丽霞,李凤云.脓毒血症1例分析[J].中国误诊学杂志,2009,9(3):725.
|
[6] |
REMICK DG.Pathophysiology of sepsis[J]. Am J Pathol,2007,170(5):1435-1444.
|
[7] |
ALI NA,O'BRIEN JM JR,DUNGAN K,et al. Glucose variability and mortality in patients with sepsis[J]. Crit Care Med,2008,36(8):2316-2321.
|
[8] |
VAN DEN BERGHE G,WOUTERS PJ,KESTELOOT K,et al. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients[J]. Crit Care Med,2006,34(3):612-616.
|
[9] |
姚咏明,孟海东.脓毒症高血糖与胰岛素强化治疗策略[J].中华危重病急救医学,2006,18(2):68-70.
|
[10] |
ROMEO GR,LEE J,SHOELSON SE.Metabolic syndrome,insulin resistance,and roles of inflammation-mechanisms and therapeutic targets[J]. Arterioscler Thromb Vasc Biol,2012,32(8):1771-1776.
|
[11] |
HIRASAWA H,ODA S,NAKAMURA M.Blood glucose control in patients with severe sepsis and septic shock[J]. World J Gastroenterol,2009,15(33):4132-4136.
|
[12] |
MARIK PE,RAGHAVAN M.Stress-hyperglycemia,insulin and immunomodulation in sepsis[J]. Intensive Care Med, 2004,30(5):748-756.
|